PARP抑制劑被認為是本世紀獲批用於治療卵巢癌的最令人振奮的新藥之一,但它僅適用於那些在DNA修復方面存在缺陷(稱為HR...
Copyright© 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.
地址: Suite 300 Level 3/489 Toorak Road, Toorak VIC 3142 電話: 03 9898 8188 電郵: (編輯部) editor_vic@epochtimes.com.au (廣告部) sales_vic@epochtimes.com.au